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Abstract 
Leptospirosis is an important worldwide zoonosis. While human leptospirosis remains 
rare in Switzerland, the incidence of canine leptospirosis is unusually high compared to 
other European countries. The aims of this cross-sectional study were to determine the 
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exposure of asymtomatic dogs to pathogenic Leptospira in Switzerland, to characterise 
risk factors associated with seropositivity and to determine the prevalence of urinary 
shedding. Sampling was stratified to cover the whole of Switzerland. Sera were tested 
by microscopic agglutination test for antibodies against a panel of 12 serovars. Urine 
was tested for pathogenic Leptospira using a LipL32 real-time PCR. Of 377 sera, 55.7% 
(95%CI 51.2-60.7) showed a reciprocal MAT titre of ≥1:40 and 24.9% (95%CI 20.7-29.4) 
of ≥1:100 to at least one serovar. Seropositivity (MAT ≥1:100) was most common to 
serovars Australis (14.9%; 95% CI 11.4-18.6) and Bratislava (8.8%; 95%CI 6.1-11.7), 
followed by Copenhageni (6.1%; 95%CI 3.7-8.5), Canicola (5%; 95%CI 2.9-7.4), 
Grippotyphosa (4.5%; 95%CI 2.7-6.9), Pomona (4%; 95%CI 2.1-6.1), Autumnalis (2.7%; 
95%CI 1.3-4.2) and Icterohaemorrhagiae (1.6%; 95%CI 0.5-2.9). In unvaccinated dogs 
(n=84) the prevalence of a MAT titre ≥100 was 17.9% (95%CI 10.7-26.2), with a similar 
distribution of reactive serovars. Variables associated with seropositivity (≥1:40) to any 
serovar included age (OR 1.29/year; 95%CI: 1.1-1.5) and bioregion with higher risks in 
the regions Northern Alps (OR 14.5; 95%CI 2.2-292.7), Central Plateau (OR 12.3; 
95%CI 2.0-244.1) and Jura (OR 11.2; 95%CI 1.7-226.7) compared to Southern Central 
Alps. Dogs living with horses were significantly more likely to have antibodies to serovar 
Bratislava (OR 4.68;95%CI 1.2-17.2). Hunting was a significant risk factor for 
seropositivtiy to serovar Grippotyphosa (OR 8.03; 95%CI 1.6-30.8). Urine qPCR 
positivity was uncommon (1/408 dogs; 0.2%; 95% CI0-0.7). These results demonstrate 
that dogs in Switzerland are commonly exposed to pathogenic Leptospira; however, the 
risk of dogs contributing to the spread of Leptospira in the environment appears low.  
Keywords: Leptospira; ; ; ; ; , Microscopic agglutination test, real time LipL32 PCR, 
urinary shedding, risk factors, dog 
1. Introduction 
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Leptospirosis is a zoonotic disease with worldwide distribution affecting most 
mammalian species (Bharti et al., 2003). It is caused by infection with pathogenic 
Leptospira spp. The organism maintains itself in nature by colonising the renal tubules 
of reservoir or maintenance hosts from which they are shed into the environment via 
urine. Maintenance hosts are often rodents, but in principle any host susceptible to 
infection can become a chronic carrier of Leptospira. Due to co-evolutionary 
adaptation, many serovars have a preference for specific maintenance hosts (e.g. rats 
often carry serovar Icterohaemorrhagiae) and cause very little clinical signs of infection 
in these hosts. In contrast, if a host gets infected with a non-adapted serovar (incidental 
host infection), acute and potentially life threatening disease can develop. Clinical 
manifestations in incidental hosts include fever, renal and hepatic injury, pulmonary 
haemorrhage and reproductive failure (Adler, 2015). In general, infected maintenance 
hosts show leptospiruria of higher intensity and longer duration compared to incidental 
hosts (Chernukcha et al., 1974; Rojas et al., 2010).  
Human leptospirosis is a major public health issue in many countries, including Latin 
America and South-East Asia, with large outbreaks linked to natural disaster and 
flooding (Abela-Ridder et al., 2010). In developed countries of temperate zones 
leptospirosis is considered a rare disease, with an increased occupational risk for   
professions such as farmers, slaughterhouse workers, sewage workers and 
veterinarians and for individuals performing outdoor activities such as fishing and water 
sports (Picardeau, 2013).  
In dogs, risk factors for acute clinical infection and exposure in asymptomatic dogs, as 
well as associations of seropositivity with environmental or climatic factors have been 
reported from a number of different areas of the world including Europe, North and 
South America; Australia and New Zealand with sometimes contradicting results. A 
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recent meta-analysis identified the following major risk factors for leptospirosis: male 
sex, mixed-breed, young dogs (<1 year), working dogs, flooding occurrence in the 
habitat of the dog and urban environment (Azocar-Aedo and Monti, 2016). Other 
possible risk factors are swimming, drinking from outdoor water and exposure to wild 
animals (Ghneim et al., 2007). 
The epidemiology of leptospirosis in Switzerland is incompletely understood. While 10-
20% of mice, moles and shrews captured in the city of Zürich showed PCR- based 
evidence of renal colonisation with Leptospira spp, more specific information on 
serovars present in the environment and their relevant maintenance hosts is currently 
not available. While the prevalence and incidence of leptospirosis in humans is 
unknown due to low awareness of the disease and lack of an official notification 
system, a cluster of acute leptospirosis in young, previously healthy persons was 
recently identified in Switzerland and traced back to a surfing spot on the river Reuss 
in canton Aargau (Schreiber et al., 2015).  
A dramatic increase in the incidence of canine leptospirosis has been documented in 
Switzerland between 2003 and 2012 with a peak incidence of 28/100.000 dogs in 
canton Aargau in 2012 (Major et al., 2014). In that study over 75% of dogs, presented 
to a veterinary university hospital developed leptospiral pulmonary haemorrhage 
syndrome, a severe and often lethal form of leptospirosis, which has previously been 
considered rare. About 70% of dogs in this cohort showed serologic evidence of 
infection with serovars Bratislava and Australis, both belonging to serogroup Australis 
(Major et al., 2014). The natural reservoir for members of this serogroup in Switzerland 
has not yet been identified. While horses are considered an important maintenance 
host for serovar Bratislava (Arent et al., 2015), it has been suspected that this serovar 
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can be equally carried by asymptomatic dogs thus potentially acting as a source of 
infection for other domestic and wild animals and for humans  (Ellis, 2010). 
Urinary shedding of pathogenic Leptospira has been reported in 1.5-8% of dogs not 
suspected to have leptospirosis (Harkin et al., 2003; Rojas et al., 2010; Llewellyn et 
al., 2016). Dog ownership has been identified as a risk factor for human leptospirosis 
in Germany (Jansen et al., 2005), Barbados (Douglin et al., 1997) and Nicaragua 
(Trevejo et al., 1998) suggesting transmission of Leptospira spp from dogs to humans.  
We hypothesised that there is a high level of exposure to pathogenic Leptospira in 
dogs in Switzerland. Furthermore we hypothesised that urinary shedding of leptospires 
is common in dogs without clinical signs of leptospirosis and that dogs may therefore 
contribute to environmental contamination. 
The aims of this present study were: 1) to estimate the level of exposure to pathogenic 
Leptospira sp. by determining the prevalence of anti-leptospiral serum antibodies, 2) 
to determine the prevalence of urinary shedding of pathogenic leptospires and 3) to 
determine risk factors for exposure to pathogenic leptospires including age, sex, breed, 
geographic area, vaccination status and lifestyle in dogs not suspected to have 
leptospirosis in Switzerland. 
2. Material and Methods 
2.1. Ethical approval 
Ethical approval was granted by the Federal Food Safety and Veterinary Office for the 
study protocol (Project BE9/15). Written owner consent was obtained before enrolment 
of dogs in the study. 
2.2. Study design, recruitment, inclusion and exclusion criteria 
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The study was designed as a cross-sectional prevalence study representing the whole 
of Switzerland. Sampling was stratified based on the number of dogs per canton 
according to the Swiss national registry for dogs (ANIS database, Animal Identity 
Service AG, Bern, Switzerland). The sample size was calculated to estimate the true 
prevalence and a significant difference between two proportions assuming a 
prevalence of 10%, test sensitivity and specificity of 95%, a power of 85% and 
confidence levels of 0.05. The estimated prevalence was based on the results of 
previous studies (Arent et al., 2013; Schuller et al., 2015); (Davis et al., 2008); 
(Llewellyn et al., 2016).  
Dogs were recruited at the Vetsuisse Faculty Bern and Zürich, as well as via 30 private 
practices throughout Switzerland between April and December 2015. Private practices 
were recruited during in-house conferences at the Vetsuisse Faculty Bern and Zürich. 
In areas with low participation, additional practices were contacted via phone and 
invited to participate. 
Dogs presented for routine check-ups, vaccination or problems unrelated to 
leptospirosis were eligible for inclusion. Dogs had preferably not been vaccinated 
against leptospirosis during the previous 16 weeks and were excluded from urine real 
time PCR (qPCR) examination if they had received antibiotics within the past 4 weeks. 
Repeated MAT testing was advised in cases with reciprocal titres of ≥1:40 in order to 
document titre dynamics.  
2.3. Sampling and Sample Handling 
2.3.1. Stability of leptospiral DNA in canine urine with and without stabilizer 
In preparation of the study the stability of leptospiral DNA in canine urine during 
simulated shipping at ambient temperature with and without a stabiliser 
(AssayAssure®; Sierra Molecular Corporation; USA) was tested. Fresh voided urine 
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from dogs without evidence of urinary tract infections as shown by absence of clinical 
signs, normal dipstick results, inactive sediment and negative bacterial culture were 
collected via free catch. Samples were pooled, split into 4 ml aliquots and spiked with 
Leptospira interrogans serovar Autumnalis at 1x104/ml, 1x103 and 1x102/ml. The strain 
L. interrogans serovar Autumnalis Akiyami was chosen due to its intermediate 
detection limit (5 Genome equivalents per reaction) determined in a previous study 
(Stettler, 2015). Stabiliser was added to the test group at a concentration of 1:11 
according to the manufacturer’s instructions. The spiked samples were incubated at 
room temperature for 4, 24 or 48 hours and then processed for DNA extraction and 
real time PCR as described below. All spiked samples incubated for 4 and 24 hours 
showed amplification of the target gene lipl32 regardless of the addition of stabiliser 
and incubation time. However, after incubation of 48 hours no positive amplification 
could be yielded without the addition of stabiliser (Suppl. Table 1). Based on these 
positive results, the stabiliser was used for all urine samples in this study.  
2.3.2. Urine samples 
Urine samples were collected via free catch unless cystocentesis was indicated for 
medical reasons. Four ml of urine were immediately transferred into polypropylene 
tubes prefilled with 0.36 ml of stabiliser (ratio 1:11).  
2.3.3. Blood samples 
Blood was collected into tubes without anticoagulant. Blood was either sent to the 
laboratory uncentrifuged or left to clot for 30 min before centrifugation at 2,000 x g for 
10 minutes and subsequent serum separation. 
2.3.4. Shipping and pre-analytical sample handling 
Urine, whole blood or serum samples were shipped at ambient temperature to the 
Department of Veterinary Bacteriology of the Vetsuisse Faculty Bern, which hosts the 
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Swiss National Reference Laboratory for animal leptospirosis and is accredited by the 
Swiss Accreditation Service (SAS) for both techniques, MAT and real-time PCR. 
Quality management is according to DIN EN ISO/IEC 17025 with regular participation 
in the proficiency testing schemes of the National Serology Reference Laboratory 
(Australia) and Vetqas AHPA (UK) for serology and real-time PCR.  
DNA extraction was performed within 48 h of sampling. Serum and DNA extracts were 
either immediately analyzed or frozen at -20°C until further analysis.   
2.4. Questionnaire 
Owners were encouraged to fill in a questionnaire addressing the following points: age, 
sex, breed, neuter status, occurrence of a febrile illness in the dog or owner in the past 
year, treatments in the past 4 weeks, life style including residential environment (urban, 
countryside, farm, presence or absence of a garden), whether the dog is mainly kept 
indoor or outdoor, contact to other pets, activities including drinking from puddles, 
swimming in natural waters, hunting, walking in the woods, contact with wild animal 
species and knowledge of confirmed cases of leptospirosis in the vicinity (Supp. 
Figure 1). The date of last vaccination and type of vaccine were either checked directly 
on the vaccination booklet by the veterinarian, or owners were asked by phone to read 
aloud the vaccination record.   
2.5. Microscopic agglutination testing (MAT) 
Sera were examined for the presence of antibodies against pathogenic Leptospira by 
microscopic agglutination test (MAT) according to OIE standards (Office International 
des Epizooties OIE, 2008).  
For MAT testing, live cultures of twelve reference strains of Leptospira belonging to 10 
serogroups were used (Table 1). Sera were initially screened for agglutination of 
Leptospira at a dilution of 1:25. Reactive sera were titrated in a serial two-fold dilution 
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to determine the end-point titre defined as the highest serum dilution at which at least 
50% agglutination occurs. All samples were tested by the same person to avoid inter-
observer variability. 
2.6. DNA extraction from urine and Real time PCR 
Urine samples were centrifuged at 10 000 rpm at 4°C for 10 min. Subsequently, the 
supernatant was discarded and the pellet resuspended in 100 µL lysis buffer 
(containing 180 ml pyrogen-free water, 20 ml TrisHCl 1M pH 8.5, 100 µL Tween 20 
and 48 mg Proteinase K (Sigma-Aldrich Co, St. Louis, Missouri, USA) and incubated 
for 60 min at 60°C, followed by 15 min at 97° on an Eppendorf thermomixer comfort 
(Vaudaux-Eppendorf AG, Basel, Switzerland). The lysates were stored at -20°C. 
The real-time PCR targeted the gene encoding leptospiral major outer membrane 
protein LipL32 which is only present in pathogenic Leptospira spp. Primers and probe 
were according to (Villumsen et al., 2012) using the following primers: LipL32F (5’-
AGA GGT CTT TAC AGA ATT TCT TTC ACT ACC T-3’), LipL32R (5’- TGG GAA AAG 
CAG ACC AAC AGA-3’) and LipL32-P (5’-FAM-AAG TGA AAG GAT CTT TCG TTG 
C-MGB-3’). The reactions were carried out on a 7500 Fast Real Time PCR System 
(Applied Biosystems, Foster City, CA, USA) with the cycling settings recommended by 
the manufacturer in a total reaction volume of 25 µL containing: 12.5 µL TaqMan® 
Universal PCR Master Mix, No AmpErase® UNG at a concentration of 100 µM, a 1 µM 
concentration of each forward and reverse primer, a 80 nM concentration of the probe, 
0.5x TaqMan® Exogenous Internal Positive Control (IPC) mix, 0.5x IPC template (all 
reagents Applied Biosystems, Foster City, CA, USA), and 2.5 µL of template. DNA 
from Leptospira interrogans serovar Icterohaemorrhagiae strain RGA was included as 
a positive control and pyrogen free water as a negative control. Values above the 
threshold of 0.06 at cycle times <40 were considered positive.  
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2.7. Statistical analyses 
A graphical overview of dogs included in the different steps of the analysis is shown in 
Figure 1. Descriptive statistics and the prevalence calculations were performed using 
IBM SPSS Statistic Version 23 for Windows. Univariate and multivariate analyses were 
performed using R 3.2.2 (2016, R Core Team, Vienna, Austria).  
MAT positivity was defined as positive reaction to at least one serovar included in the 
12 serovar panel at reciprocal titres of ≥1:40 (ALL40) or ≥1:100 (ALL100). Two, instead 
of one cut-off titres were chosen in the absence of a consensus to what represents an 
ideal cut-off titre to document exposure in a population of dogs not suspected to have 
leptospirosis.  
The prevalence of positive urine qPCR and MAT seropositivity were calculated with a 
confidence interval of 95%. In order to examine the possible effect of vaccination on 
MAT seropositivity, seroprevalence was calculated for the overall population as well 
as for the group of unvaccinated dogs (n=84) and the group of dogs not vaccinated 
within the past 16 weeks (n=255).  
Risk factor analysis was restricted to MAT seropositivity as outcome measure because 
only one dog tested positive on qPCR. Risk factor analysis was performed using the 
whole study population and without exclusion of vaccinal serogroups 
(Icterohaemorrhagiae, Canicola, Australis, Grippotyphosa). To test for the potential 
effect of vaccination on MAT seropositivity, the variable “days since vaccination” was 
introduced into the analysis. For unvaccinated dogs a value had to be generated in 
order to incorporate them into the model and 700 days was regarded a period after 
which antibodies were present due to exposure to leptospires and not due to 
vaccination. In order to identify risk factors, the association of independent variables 
derived from the questionnaire and the newly generated variable “days since 
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vaccination” with MAT seropositivity at reciprocal titres of ≥1:40 (ALL40) or ≥1:100 
(ALL100) were assessed. In a second step risk factors for seropositivity (MAT ≥1:100) 
was assessed for the serovars Australis (AUS100), Bratislava (BRA100), 
Grippotyphosa (GRI100), Canicola (CAN100) and Copenhageni (COP100), which 
were the serovars that sera most commonly reacted with. Variables included in the risk 
factor analysis are shown in Table 2. 
Univariate analysis was performed using χ2 or Fisher's exact test for categorical 
variables and univariate logistic regression for continuous variables. A value of p ≤ 0.20 
was considered as the critical level of significance for a variable to be entered in a full 
multivariable logistic regression model. Subsequently, for each outcome a manual 
likelihood-ratio-test backward selection of exposure variables was used to determine 
the best fitting model and to determine independent potential risk or confounding 
factors associated with Leptospira seropositivity. Risk factors were maintained in the 
model at a p-value ≤ 0.05.  
The assumption of independence of the data was potentially violated, since some dogs 
were owned by the same owner and thus were clustered. To correct for dependency, 
we explored extending the model by generalised estimating equations (GEE) to control 
for clustering, by expanding the standard errors (SE) (‘robust SE’) and increasing the 
p-values. An independence and exchangeable pattern was used as correlation 
structure (Liang, 1986). However, the SE hardly changed and therefore the results of 
unadjusted multivariable logistic regression models were reported. The final models 
were evaluated on goodness of fit using the Hosmer-Lemeshow test. The models 
showed no evidence of lack of fit and there was no strong leverage. All observations 
were therefore kept in the model. Influential observations were detected using Pearson 
residuals, hat matrix (leverage) and delta-betas (Hosmer, 2004). 
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For analysis of geoclimatic factors on seroprevalence, the Swiss Territory was 
categorized into six bioregions according to a classification proposed by the Swiss 
Federal Office for the Environment (BAFU) (Gonseth, 2001). The six regions were 
Jura, Central Plateau, Northern Alps, Central Western Alps, Central Eastern Alps and 
Southern Alps; each bioregion presenting similar geological, geomorphological and 
climatic conditions (Figure 2).  
2.8. Mapping 
Maps were created using QGIS 2.14 (QGIS Development Team, 2016. QGIS 
Geographic Information System. Open Source Geospatial Foundation Project) 
3. Results 
3.1. Study population  
The sample size to estimate a true prevalence and to identify risk factors with sufficient 
statistical power was estimated to be 229 and 536 dogs, respectively. 
The majority of dogs included in this study were privately owned pet dogs. Eleven dogs 
were owned by the military, but lived in individual homes with their handlers. 21 dogs 
lived in two different rehoming kennels.  
Of the 377 dogs tested by serology, 21.1% lived in urban areas and 73.1% in rural 
environments including 16.9% farm dogs. 
Dogs originated from 20 of the 26 Swiss cantons. The geographical distribution of the 
sampled dogs across Switzerland is shown in Figure 3.  
The age of the dogs ranged from 4 months to 15 years (median 5 years IQR 2-9). Of 
the 423 dogs of known breed, 341 (80.6%) were purebred from 102 different breeds 
and 82 dogs (19.3%) were mixed-breeds. The most common breeds were Malinois 
(8.3%), Labrador Retriever (7.8%), French Bulldogs (4%), Golden Retrievers (3.5%) 
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and Jack Russel Terrier (3.3%). The overrepresentation of Malinois dogs was due to 
the inclusion of military dogs as well as dogs of this breed undergoing genetic 
screening. Gender was known in 97.8% of dogs and was equally distributed with 204 
(45.3%) female dogs (57 entire/146 neutered) and 246 (54.7%) male dogs (139 
entire/107 neutered).  
Of the 377 dogs tested by MAT, 373 had a known vaccination history: 43 dogs (11.6%; 
95%CI 40.6-50.7) were vaccinated using a bivalent vaccine including serovars 
Canicola, and Icterohaemorrhagiae, 246 (66.3%; 95%CI 61.2-70.9) with a quadrivalent 
vaccine including serovars Canicola, Grippotyphosa, Icterohaemorrhagiae and 
Pomona and 84 dogs (22.1%; 95%CI 18.1-26.4) were not vaccinated. The median 
period between vaccination and test was 252.5 days (IQR 161-342). 
3.2. Urinary shedding 
qPCR of urine was performed for 408 dogs without clinical suspicion of leptospirosis. 
Only one dog had a positive PCR result. This dog lived on a farm in Canton Vaud and 
reportedly had a habit of chasing rats. The dog showed reciprocal MAT titres of 1:40 
to serovar Bratislava and 1:20 to serovars Australis, Canicola, Hardjo and Autumnalis. 
The dog had been vaccinated with a bivalent anti-leptospiral vaccine 93 days before 
sampling. 
In 12 dogs qPCR was repeated 2-4 weeks after initial testing because of MAT titres 
≥1:40 to one or several serovars. All the repeated urine samples tested negative. 
3.3. Seroprevalence and Serovars  
Due to the potential effect of vaccination on MAT seroreactivity is shown for the overall 
population as well as according to the vaccination status of the dogs in Figure 4 A-D. 
While reciprocal tires of ≥1:40 and ≥1:100 were chosen as cut offs for risk factor 
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analysis, the prevalence of MAT seroreactivity was calculated for titres between ≥1:20 
and ≥1:3200 and are shown in Tables 3-4 and Suppl. Tables 3-4.  
3.3.1. Overall population 
Of 377 sera, 55.7% (95%CI 51-60.7) showed a reciprocal MAT titre of ≥1:40 and 24.9% 
(95%CI 20.7-39.4) of ≥1:100 to at least one serovar.  
At ≥1:100, seropositivity was most common to serovars Australis (14.9%; 95%CI 11.4-
18.6) and Bratislava (8.8%; 95%6.1-11.7), folowed by Copenhageni (6.1%; 95% 3.7-
8.5), Canicola (5%; 95%2.9-7.4), Grippotyphosa (4.5%; 95% 2.7-6.9), Pomona (4%; 
95%2.1-6.1), Autumnalis (2.7%; 95%1.3-4.2) and Icterohaemorrhagiae (1.6%; 95%0.5-
2.9).  
At ≥1:40 the reactivity pattern was slightly different with Australis (32.6; 95%CI 28.1-
32.6, Canicola (24.9; 95%CI 20.7-29.4), and Copenhageni (18.3; 95%CI 14.3-22.5) 
being the most commonly reactive serovars, followed by Bratislava (14.3; 95%CI 10.6-
18), Grippotyphosa (11.4; 95%CI 8.2-14.9), Icterohaeorrhagiae (9.5; 95%CI 6.9-12.7) 
and Pomona (9.8; 95%CI 6.9-13).  
In order to better understand the differences in reactivity, co-reactiviy patterns were also 
analysed (Table 5). The number of dogs with MAT reactivity to more than one serogroup 
was higher at a cut-off titre of ≥1:40 than at a cut-off titre of ≥1:100. The most common 
serogroup co-reactivities or double exposures at a MAT cut-off of ≥1:100 were serogroup 
Australis and Icterohaemorragie (40%), Australis and Grippotyphosa (28.6%), Australis 
and Pomona (28.6%) and Canicola and Icterohaemorrhagie (25.7%).  
3.3.2. Dogs not vaccinated in the past 16 weeks.  
Of 339 sera, 52,8% (95%CI 47.5-58.1) were reactive at a MAT titre of ≥1:40 and 22.7% 
(95%CI 18-27.4) of ≥1:100 to at least one serovar. Seropositivtiy (MAT ≥1:100) was most 
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common to serovars Australis (13%; 95%CI 9.7-16.5), Bratislava (8.3%; 95%CI 5.6-
11.5), Canicola (4.7%; 95%CI 2.7-7.1), Copenhageni (4.7%; 95%CI 2.7-7.1), 
Grippotyphosa (1.5%; 95%CI 2.4-6.8), Pomona (3.5%; 95%CI 1.8-5.6), Autumnalis 
(2.9%; 95%CI1.5-5) and Icterohaemorrhagiae (1.5%; 95%CI 0.3-2.9). 
3.3.3. Unvaccinated dogs.  
In unvaccinated dogs (n=84) the overall seroprevalence was 44% (95%CI 33.3-53.6) at 
a reciprocal MAT titre of ≥1:40 and 17.9% (95%CI 10.7-26.2) at a reciprocal MAT titre of 
≥1:100. The distribution of serovars was largely similar to the distribution in vaccinated 
dogs with Australis (9.5%; 95%CI 3.6-16.6), Bratislava (8.3%; 95%CI 2.4-14.3) being 
the most frequent serovars, followed by Copenhageni (3.6%; 95%CI 0-8.3), 
Grippotyphosa (3.6%; 95%CI 0-8.3), Canicola (3.6 95%CI 0-8.3), Pomona (2.4%; 
95%CI 0-6) and Autumnalis (2.4%; 95%CI 0-6).  
3.3.4. MAT titre dynamics 
Despite the fact that in the study protocol retesting was advised in dogs with reciprocal 
MAT titres ≥1:40, only 11 dogs were retested after 2-3 weeks; one reason being that 
many dogs were sampled for this study immediately prior to vaccination and thus no 
meaningful information could be derived from repeat MAT testing due to the 
interference of vaccinal titres. One dog showed seroconversion (BRA: 1:400 to 1:1600) 
and one dog showed persistently high titres (BRA: 1:800 to 1:1600; AUT: 1:1600 to 
1:1600), which can be consistent with recent infection. Four dogs showed decreasing 
titres and five dogs the same or a slightly higher titre as before.  
3.4. Risk factor analysis and multivariable models 
The prevalence of anti-leptospiral serum antibodies by sex, gender, neuter status, 
vaccination status, region and lifestyle is reported in Suppl Table 2. 
3.4.1. Univariate analysis  
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The association of 17 variables for the outcomes MAT seropositivity at titres ≥40 or ≥100 
to any serovar or ≥100 to individual serovars were assessed via univariate analysis. The 
10 variables with significant (p≤ 0.2) associations with the different outcomes in the 
univariate analysis are shown in Table 6.  
3.4.2. Multivariable analysis 
The fitted models after backwards selection based on the likelihood ratio test are 
displayed in Tables 7 and 8.  
Dogs living in the bioregions Jura, Central Plateau. Northern Alps and Central Eastern 
Alps had significantly higher odds of being seropositive for any serovar compared to 
the bioregion Southern Alps.  
The odds of seropositivity to any serovar significantly increased with age at both cut 
off titres ≥1:40 and ≥1:100. The interaction between “Age” and “Days since vaccination” 
was significant for both cut off titres, meaning that the effect of age on seropositivity 
differed according to the amount of days between vaccination and test. 
Being castrated significantly increased the odds of seropositivity against serovar 
Australis (MAT ≥1:100). The odds of seropositivity with the serovar Bratislava (MAT≥ 
1:100) significantly increased when the household owned a horse. 
Hunting significantly increased the odds to be seropositive for serovar Grippotyphosa. 
For the serovars Canicola and Copenhageni no risk factors remained significant.  
4. Discussion 
4.1. Seroprevalence  
The results of this stratified cross-sectional study demonstrate that exposure to 
pathogenic Leptospira is common in dogs not suspected to have leptospirosis in 
Switzerland. Of 377 dogs tested, 24.9% showed seroreactivity to one or several 
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serovars of a 12 serovar MAT panel at a cut-off titre of ≥100 and 55.7% of dogs showed 
reactivity at a titre of ≥40. The seroprevalence of anti-leptospiral antibodies in 
asymptomatic dogs reported in the literature ranges between 6% in dogs in Ireland 
using a MAT cut-off of ≥1:10  (Schuller et al., 2015), 11.4% in Greece (Burriel et al., 
2003), 17% in dogs in southern Germany (Llewellyn et al., 2016), 17.1% in Washington 
State, 21.5% in Poland (Krawczyk, 2005) and 49% in kenneled dogs in Italy using all 
a cut off  ≥1:100 (Scanziani et al., 2002). In comparison, the overall seroprevalence of 
24.9% in Switzerland does not appear exceedingly high, especially in view of the very 
high incidence of acute disease in this region in the past years (Major et al., 2014). A 
possible explanation is that albeit dogs do not seem to get more commonly exposed 
to pathogenic Leptospira, serovars in circulation may be particularly virulent causing 
acute and severe disease in those dogs that do get infected. Another potential 
explanation could be that we are already seeing a change in epidemiology of canine 
leptospirosis in Switzerland due to the introduction of new quadrivalent vaccines, by 
the end of 2014. These vaccines contain serovars belonging to the serogroups 
Australis and Grippotyphosa in addition to serogroups Canicola and 
Icterohaemorrhagiae and thus potentially provide a broader spectrum of protection. 
4.2. Reactive serogroups 
Serovars Australis and Bratislava, both belonging to serogroup Australis, were 
associated with about half of the reactive MATs, regardless of the vaccination status 
of the dogs. These findings correlate with the fact that based on serological data, 
members of serogroup Australis are an important cause of acute clinical infection in 
dogs in Switzerland (Major et al., 2014). However, canine sera also reacted with a 
broad range of other serovars including Copenhageni, Canicola, Grippotyphosa, 
Pomona, Autumnalis and Icterohaemorrhagiae indicating that Leptospira belonging to 
these serovars are in circulation in the environment. Studies are underway to examine 
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the role of wild animals as reservoir hosts for specific serogroups in Switzerland. Serovar 
Bratislava has been isolated from hedgehogs in Ireland (Hathaway et al., 1983) and 
have been suggested as potential reservoir of serovars belonging to serogroup Australis 
in France (Ayral et al., 2016). Hedgehogs are frequent visitors in private gardens, and 
thus can come into close contact with residing dogs. The role of hedgehogs as reservoir 
host for serovars belonging to serogroup Australis in Switzerland should therefore be 
further investigated.  
4.3. Risk factors 
In order to assess areas of increased risk, the prevalence amongst 6 different 
biogeographic regions was compared. This bioregion classification is based on the 
flora and fauna found in different areas of Switzerland and reflects the significant 
climatic variations between lower Switzerland (Plateau), with low to moderate altitudes 
(230- 960 m NN), the Jura with medium to high altitudes (360-1300 m NN), the northern 
and southern slopes of the Alps and the high alpine areas with altitudes of up to 4600 
m NN (Gonseth, 2001). This classification does not take into account the potentially 
significant regional variations in microclimate, as well as other factors of importance to 
the transmission of Leptospira such as the presence of stagnant water and the density 
of wildlife populations.  
The stratification of sampling was performed independently of the bioregion 
classification and was based on the numbers of registered dogs per canton. However, 
the stratification naturally reflected the significant regional differences in density of the 
canine dog population, with the highest population density in the Plateau area (around 
75% of the human population and more than 50% of the canine population) and the 
lowest in the central alpine regions. As a consequence, the estimates of 
seroprevalence in the Alpine regions of the country were based on much smaller 
19 
 
numbers than in the Plateau and Jura regions, potentially leading to a higher margin 
of error for the lower populated areas.   
The prevalence of anti-leptospiral serum antibodies varied significantly between 
different bioregions. While the seroprevalence in the western high alpine regions 
(6.7%) and the south side of the Alps (10%) was low, the seroprevalence in the 
Northern half of the country which includes the Plateau, Jura and Northern Alps, 
ranged between 25.2% and 28.8% and odds ratios for seropositivity in these areas 
were high. The higher seroprevalence in bioregions with lower altitudes is biologically 
plausible due to less extreme climatic conditions throughout the year. Periods of 
extreme cold or extreme hot can be associated with reduced availability of surface 
water and reduced seropositivity rates, because leptospires are killed by freezing or 
desiccation (Adler, 2015). In addition to a milder climate, lower Switzerland has a large 
number of lakes and rivers, which could facilitate indirect transmission of Leptospira. 
However, none of the variables such as “swimming” and “drinking from puddles” 
assessing exposure to surface water as potential risk factors for seropositivity 
remained significant in the multivariate analysis.  
The higher seroprevalence in this cohort of dogs not suspected to have leptospirosis 
in the Jura and Plateau area correlates with previous studies describing the geographic 
distribution of dogs with acute clinical infection in Switzerland with 75.5% of dogs 
originating from the Plateau area (Major et al., 2014). A cluster of acute disease in 
humans was recently described and could be traced back to a surfing spot in canton 
Aargau, which is also situated in the plateau area (Schreiber et al., 2015). Based on 
these studies, the plateau region which includes numerous lakes and rivers appears 
to carry this highest risk of infection in Switzerland. 
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Dogs had 4.7 times higher odds of being seropositive to serovar Bratislava (MAT 
≥1:100) if the owner also owned a horse. While horses can get infected with a wide 
range of leptospiral serovars, globally, reactivity to serovar Bratislava is most common 
and the horse is considered a maintenance host for this serovar (Ellis et al., 1983; 
Baverud et al., 2009; Adler, 2015; Arent et al., 2015). In a recent serologic survey from 
Switzerland, 58.5% of 615 tested horses showed MAT seropositivity to at least one 
serogroup, indicating current or recent infection. The most frequent reactive serovars 
were Pyrogenes (22.6%), Canicola (22.1%), Australis (19.2%) and Bratislava (15.9%) 
(Blatti et al., 2011). Horses could therefore be the source of exposure for dogs to 
serovar Bratislava. However, serovar Bratislava has also been isolated from other 
animals including badgers (Hathaway et al., 1983), hedgehogs, rats and sheep (Arent 
et al., 2016). Therefore other factors such as spending more time in nature and 
potentially increased contact with reservoir hosts while accompanying the owner on 
excursions on horseback could be equally important factors for dogs to get exposed to 
this serovar. 
Dogs had 8 times higher odds of having a positive titre to serovar Grippotyphosa (MAT 
≥1:100) if they were hunting. This association may be explained by increased contact 
to environmental sources and reservoir hosts of Leptospira and correlates with the 
higher odds for acute leptospirosis in dogs exposed to wild animals (Ghneim et al., 
2007). Hunting as a risk factor for leptospirosis is also supported by human data 
showing a high seroprevalence of leptospirosis in human hunters (Deutz et al., 2003a; 
Deutz et al., 2003b).  
In this cohort, the odds of MAT seropositivity increased with increasing age. A 
correlation between age and MAT seropositivity has been shown in many other studies 
in horses (Kitson-Piggot and Prescott, 1987; Baverud et al., 2009; Blatti et al., 2011) 
21 
 
and dogs (Harland et al., 2013). This relationship is plausible as infection related 
antibodies can persist for years and the probability of having come in contact with an 
infectious agent increases over time. 
More difficult to explain is the fact that being castrated was a significant risk factor for 
the seropositivity to serovar Australis (MAT ≥1:100). This finding is in contrast to 
previous studies showing that uncastrated dogs are overrepresented in cohorts of 
animals with acute clinical leptospirosis which lead to the hypothesis that sexually 
intact animals manifest more often risky behaviours like sniffing around and marking 
their territories (Ward et al., 2002; Major et al., 2014). However, due to the confounding 
influence of vaccination on this variable, the association between neuter status and 
seropositivity to serovar Australis should not be over interpreted.    
A significant association between the living environment and seroprevalence was not 
found in this cohort of dogs. While and increased seroprevalence was found in some 
studies for dogs living in rural compared to urban areas (Ghneim et al. 2006), a recent 
meta-analysis identified a higher risk in urban environments (Azocar-Aedo & Monti, 
2016). This is not surprising, as wildlife reservoirs can be found with high density in 
both urban and rural environments and represent a likely source of infection in both 
settings. Risk factors for exposure to pathogenic Leptospira identified in other studies 
include being male or living in a kennel (Scanziani et al., 2002), a higher risk of infection 
in mixed and working breeds  (Harland et al., 2013; Azocar-Aedo and Monti, 2016) as 
well as in dogs used to swimming and drinking from outdoor sources of water (Ghneim 
et al., 2007). None of these risk factors was confirmed in this cohort of dogs. 
4.4. MAT, co-reactivities, potential confounding effects of vaccination 
In the past the MAT has been widely used to determine previous exposure to 
Leptospira in domestic and wild animals and in humans (Adler, 2015). With this test, 
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the presence of anti-leptospiral IgG and/or IgM is determined based on agglutination 
of live Leptospira species after incubation with patient serum at various dilutions.  The 
MAT relies not only on inclusion of a representative panel of Leptospira spp., but its 
interpretation also has an element of subjectivity, which can explain the significant 
variability noted when MAT results from the same patient are compared across 
different laboratories (Miller et al., 2011).  
MAT has limited specificity with regards to the identification of the infecting serogroup 
in acute infection as patient IgM, which predominates in early infection, has lower 
binding specificity than IgG (Chernukha et al., 1976). Although not supported by 
evidence, it is assumed that IgG predominates in sera of patients that have previously 
been exposed thus providing more specific information on MAT serogroup specific 
reactivity patterns than acute sera. However, cross-reactivity between different 
serogroups can occur and lead to MAT reactivity at lower dilutions.  
While the MAT is far from being a perfect method, it is currently the only tool available 
to document exposure in dogs not considered to be acutely infected (and not actively 
shedding). Despite its limitations the MAT is well accepted and extensively used to 
derive information about infecting serogroups in acutely sick (Boutilier et al., 2003; 
Ward et al., 2004; Ghneim et al., 2007; Hennebelle et al., 2013; Mayer-Scholl et al., 
2013; Major et al., 2014) and in asymptomatic dogs (Davis et al., 2008; Arent et al., 
2013; Schuller et al., 2015; Llewellyn et al., 2016). MAT-derived serogroup specific 
information has also been used to inform recommendations regarding the inclusion of 
additional serogroups into current anti-leptospiral vaccines (Ellis, 2010).  
The authors are not aware of any study in dogs, correlating infecting serovar and MAT 
serogroup reactivity. Data in this respect is missing as it would so far have required 
culture and isolation of Leptospira from infected dogs, which is notoriously difficult. As 
23 
 
molecular typing tools that do not require previous leptospiral culture are being 
developed, those methods will allow estimating the precision of serogroup 
determination via MAT in dogs, and will be a very powerful tool to type Leptospira 
causing acute infection in dogs. For this project we had planned to complement the 
serologic data with molecular typing of Leptospira spp derived from PCR positive urine. 
This part of the study would have added very valuable additional information to be 
correlated with serologic data. However, due to the very low rate of shedding, this part 
of the project could not be pursued further. 
The sensitivity and specificity of MAT in convalescent sera of dogs after acute clinical 
infection has been reported to be 100% and 92% respectively at a cut off titre of ≥1:800. 
However, this is of limited relevance to this population of dogs without clinical signs of 
acute leptospirosis. The sensitivity and specificity of the MAT in detecting chronic 
subclinical infection or post exposure titres has not been reported. The estimated 
prevalence of 10% used for power calculation was chosen after review of the recent 
literature reporting seroprevalence rates between 6% in dogs in Ireland using a MAT 
cut-off of ≥1:10 (Schuller et al., 2015), 11.4% in Greece (Burriel et al., 2003), 17% in 
dogs in southern Germany (Llewellyn et al., 2016), 17.1% in Washington State (Davis 
et al., 2008), 21.5% in Poland (Krawczyk, 2005) and 49% in kenneled dogs in Italy 
using all a cut off ≥1:100 (Scanziani et al., 2002). In the absence of a consensus of 
what represents an ideal cut off titres for MAT positivity, the decision was made to use 
two different cut offs (≥1:40 and ≥1:100) to calculated seroprevalence in this present 
study.  
As expected, co-reactivities were more common at lower titres. Most common co-
reactivities were those between serogroups contained in the current vaccines and 
could therefore be related to vaccination. The MAT does not discriminate between 
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vaccination titres and titres due to exposure, thus adding further difficulty to the 
interpretation of canine tests, as a large proportion of dogs are vaccinated with either 
bivalent or quadrivalent whole cell anti-leptospiral vaccines. Despite all these 
limitations we decided to use MAT to estimate the seroprevalence in dogs not 
suspected to have leptospirosis in Switzerland and to apply statistical methods to 
minimise the effect of vaccination on prevalence results. In the absence of specific data 
regarding antibody titres after vaccination with a quadrivalent vaccine available on the 
European market at the time of the planning of the study, the results of a study 
describing the dynamics of antibody titres after vaccination with anti-leptospiral 
vaccines available on the US market were used to define inclusion criteria with regards 
to vaccination. In this study the majority of dogs developed positive MAT titers 
immediately after vaccination, a minority of them remained seropositive by week 15 
(Martin et al., 2014). On the basis of these results, we decided to select dogs 
vaccinated at least 16 weeks (112 days) before testing. Due to the multicentre design 
of this study, this inclusion criterion was however violated in 10% of dogs. Subgroup 
analysis between vaccinated and unvaccinated dogs, as well as dogs not vaccinated 
in the past 112 days showed that albeit seroprevalence was slightly lower if recently 
vaccinated dogs were excluded, there was good correlation with regards to the reactive 
serogroups, in particular if considering the MAT titres ≥1:100.Therefore the decision 
was made to perform risk factor analysis on the entire cohort, regardless of vaccination 
status and to introduce the variable “days since vaccination” as a risk factor in the 
model to account for the possible confounding effect of vaccination. This variable only 
remained significant as an effect modifier for the associations between age and MAT 
seropositivity and for the association between castration and MAT seropositivity. We 
are therefore confident that the presented risk factors reflect risk factors associated 
with natural infection and not vaccination.  
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In order to describe titre dynamics in dogs with MAT titres ≥1:40 follow up testing 1-2 
weeks later was advised. However, a large proportion of dogs was tested immediately 
prior to vaccination precluding that information of relevance to this study could be 
retrieved from retesting. Therefore only a small proportion of dogs was retested and 
results consistent with recent infection was found in 18% (2/11) of these dogs. 
4.5. Urinary shedding 
One of the hypotheses tested in this study was that dogs contribute to the maintenance 
and spread of pathogenic Leptospira in the environment by shedding Leptospira in 
their urine. In that regard urine samples from 408 dogs were tested by qPCR. Care 
was taken to preserve leptospiral DNA during shipment by use of a stabiliser, which 
had shown to preserve leptospiral DNA for at least 48 h post sampling. However, only 
1/408 samples tested positive. In this dog contact to small rodents was the likely source 
of infection however and material was insufficient for molecular typing of the serovar 
or species level. Based on these results we concluded that urinary shedding by 
asymptomatic dogs is uncommon. This could be explained by the fact that dogs, albeit 
being an important incidental host for serogroup Australis in Switzerland, does not 
appear to be an efficient maintenance host for any of the locally prevalent strains, not 
included in the current vaccines. However, the influence of intermittent shedding and 
lack of detection due to pre-analytical or analytical factors also need to be considered 
and could potentially lead to a large underestimation of the actual level of renal carriage 
of pathogenic Leptospira in the canine population (Gay et al., 2014).  
5. Conclusions 
In conclusion, the results of this study show that dogs in Switzerland are commonly 
exposed to pathogenic Leptospira spp. with exposure being most common to serovars 
belonging to serogroup Australis. The Swiss Jura and plateau regions carry the highest 
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risk of infection. Contact to horses and hunting were significant risk factors associated 
with seroprositivity to serogroups Bratislava and Gripotyphosa respectively. Based on 
our findings vaccination of dogs with quadrivalent vaccines containing serogroups 
Australis and Gripotyphosa in addition to serogroups Icterohaemorrhagiae and Canicola 
is advised. The risk of dogs contributing to the spread of pathogenic Leptospira in the 
environment appears low. 
Acknowledgements 
This study was funded by the Federal Food Safety and Veterinary Office (Project 
1.15.02). We would like to thank all veterinarians, veterinary staff and dog owners who 
participated in the study. We would also like to thank Valentine Jaquier und Isabelle 
Brodard for excellent technical assistance with the serological and molecular analyses. 
This study was presented as an oral abstract at the 26th annual congress of the 
European College of Veterinary Internal Medicine (ECVIM-CA) in Gothenburg (9.9.-
10.9.2016). 
  
27 
 
 
Figure legends  
Figure 1. Graphical overview of stdy population and statistical analyses MAT: 
Microscopic agglutination test; RT-PCR: LipL32 real time PCR 
AUS: Australis; CAN: Canicola, GRI: Grippotyphosa, ICT: Icterohaemorrhagie  
 
Figure 2. The biogeographic regions of Switzerland defined by Gonseth and 
Wohlgemuth (2001). The six biogeographic regions of Switzerland and the number of 
MAT seropositive dogs per total tested at a cut-off ≥ 1:40 and ≥ 1:100 are shown. 
 
Figure 3. The geographical distribution of 377 dogs tested for serum antibodies 
against Leptospira spp via MAT. Geocoding was performed based on the zip code 
of the owner’s home address. Seropositivity was defined as positive MAT titre at 
≥1:100. Borders indicate the biogeographic regions of Switzerland defined by Gonseth 
and Wohlgemuth (2001). 
 
Figure 4: Relative prevalence (%) of MAT reactivity to any serovar (All) and to 
individual serovars at reciprocal titres of ≥1:100 (A, C) and ≥1:40 (B, D). 
Prevalence is shown for vaccinated and non-vaccinated dogs (A-B), as well as 
between dogs vaccinated with a bi-valent and quadrivalent anti-leptospiral vaccines 
(C, D). Tested serovars: Australis (AUS), Autumnalis (AUT), Ballum (BAL), Bratislava 
(BRA), Canicola (CAN), Copenhageni (COP), Grippotyphosa (GRI), Hardjo (HAR), 
Icterohaemorrhagie (ICT), Pomona (POM), Pyrogenes (PYR) and Tarassovi (TAR). 
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Tables 
 
Table 1. Panel of 12 Leptospira spp. used as live antigens for Microscopic  
Agglutination testing (MAT). 
 
Genomospecies Serogroup Serovar Strain 
L.interrogans Australis Australis Ballico 
  Australis Bratislava Jez-Bratislava 
  Autumnalis Autumnalis Akiyami 
  Canicola Canicola Hond Utrecht IV 
  Icterohaemorrhagiae Icterohaemorrhagiae RGA 
  Icterohaemorrhagiae Copenhageni M20 
  Pomona Pomona Pomona 
  Pyrogenes Pyrogenes Salinem 
  Sejroe Hardjo Hardjoprajitno 
L.borgpetersenii Ballum Ballum Mus127 
 Tarassovi Tarassovi Perepelitsin 
L. kirschneri Grippotyphosa Grippotyphosa Moskva V 
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Table 2. Frequency of variables collected via questionnaire for dogs tested for anti-
leptospiral serum antibodies via MAT.  
 
Variable Category n % 95%CI 
Vaccine Not vaccinated 84 22.5% 18.2-26.5 
Bivalent  43 11.5% 8.3-14.7 
Quadrivalent  246 66% 61.1-71 
Sex Female 170 46.1% 41.2-51.2 
Male 199 53.9% 48.8-58.8 
Castrated No 168 45.7% 40.6-50.7 
Yes 200 54.3% 49.3-59.4 
Other animals in the household No 107 31.2% 26.3-36.1 
Dog 117 34.1% 29.1-39.1 
Cat 59 17.2% 13.2-21.2 
Dog and Cat 32 9.3% 6.3-12.4 
Livestock +/-Dog/cat  5 1.5% 0.2-2.7 
Horses +/- Dog/cat 23 6.7% 4.1-9.4 
Bioregion Jura 51 13.5% 10.1-16.7 
Central Plateau 230 61% 56.2-65.8 
Northern Alps 66 17.5% 13.8-21.5 
Central western Alps 15 4% 2.1-6.1 
Central Eastern Alps 5 1.3% 0.3-2.7 
Southern Alps 10 2.7% 1.3-4.5 
Surrounding Shelter 21 5.8% 3.6-8.3 
Urban 49 13.6% 10-17.2 
Rural 98 27.1% 23-31.9 
Farm 61 16.9% 13-20.8 
Urban + Garden 27 7.5% 5-10.2 
Rural + Garden 105 29.1% 24.4-33.8 
Contact to acutely ill animals No 162 47.9% 42.3-53.3 
Yes 28 8.3% 5.6-11.5 
I do not know  148 43.8% 38.2-49.1 
Previously diagnosed and treated for 
Leptospirosis  
No 330 97.6% 95.9-99.1 
Yes 8 2.4% 0.9-4.1 
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Fever this past year (dog)  No 305 90.2% 87-93.5 
Yes 33 9.8% 6.5-13 
Fever this past year (owner) No 270 81.1% 77.2-85.3 
Yes 63 18.9% 14.7-22.8 
Outside <50% of time 259 75.7% 71.3-80.1 
>50% of time 83 24.3% 17.6-31.3 
Spends time in forests No 31 9.2% 6.2-12.4 
Yes 307 90.8% 87.6-93.8 
Drinking from puddles No 104 30.9% 26.1-35.9 
Yes 233 60.1% 64.1-73.9 
Swimming  No 110 32.7% 27.7-37.8 
Yes 226 67.3% 62.2-72.3 
Contacts to wild animals No 190 56.2% 50.6-61.5 
Yes 94 27.8% 23.4-32.5 
I do not  know 54 16% 12.1-20.1 
Hunting No 326 96.4% 94.4-98.2 
Yes 12 3.6% 1.8-5.6 
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Table 3.  Number of individuals, relative prevalence and 95% CI per Leptospira serovar for all dogs (n=377). Tested serovars: 
Australis (AUS), Autumnalis (AUT), Ballum (BAL), Bratislava (BRA), Canicola (CAN), Copenhageni (COP), Grippotyphosa (GRI), Hardjo 
(HAR), Icterohaemorrhagie (ICT), Pomona (POM), Pyrogenes (PYR) and Tarassovi (TAR). 
 
MAT 
Titer 
 All 
Serovars AUS BRA COP CAN GRI ICT POM PYR TAR AUT BAL HAR 
≥1:20 
n 276 236 76 115 170 60 64 68 22 9 64 51 2 
% 73.2 62.6 20.2 30.5 45.1 15.9 17 18 5.8 2.4 17 13.5 0.5 
CI 69-77.7 57.8-67.6 15.9-24.4 26-35.3 40.1-50.1 11.9-19.9 13.3-20.7 14.3-22 3.4-8.5 1.1-4 13.3-21 10.1-17 0-1.3 
≥1:40 
n 210 123 54 69 94 43 36 37 7 2 27 3 1 
% 55.7 32.6 14.3 18.3 24.9 11.4 9.5 9.8 1.9 0.5 7.2 0.8 0.3 
CI 50.4-61 28.1-37.4 10.6-18 14.3-22.5 20.7-29.4 8.2-14.9 6.9-12.7 6.9-13 0.5-3.2 0-1.3 4.5-9.8 0-1.9 0-0.8 
≥1:100 
n 94 56 33 23 19 17 6 15 3 1 10 - - 
% 24.9 14.9 8.8 6.1 5 4.5 1.6 4 0.8 0.3 2.7 - - 
CI 20.4-29.4 11.4-18.6 6.1-11.7 3.7-8.5 2.9-7.4 2.7-6.9 0.5-2.9 2.1-6.1 0-1.9 0-0.8 1.3-4.2 - - 
≥1:200 
n 46 21 20 11 7 9 3 6 2 - 5 - - 
% 12.2 5.6 5.3 2.9 1.9 2.4 0.8 1.6 0.5 - 1.3 - - 
CI 9-15.6 3.4-8 3.2-7.7 1.3-4.8 0.5-3.4 1.1-4 0-1.9 0.5-2.9 0-1.3 - 0.3-2.7 - - 
≥1:400 
n 23 9 11 3 - 1 1 2 - - 3 - - 
% 6.1 2.4 2.9 0.8 - 0. 0.3 0.5 - - 0.8 - - 
CI 4-8.8 1.1-4 1.3-4.5 0-1.9 - 0-0.8 0-0.8 0-1.3 - - 0-1.9 - - 
≥1:800 
n 8 5 5 - - 1 - 1 - - 1 - - 
% 2.1 1.3 1.3 - - 0.3 - 0.3 - - 0.3 - - 
CI 0.8-3.7 0.3-2.7 0.3-2.7 - - 0-0.8 - 0-0.8 - - 0-0.8 - - 
≥1:1600 
n 6 4 1 - - - - - - - 1 - - 
% 1.6 1.1 0.3 - - - - - - - 0.3 - - 
CI 0.5-2.9 0.3-2.1 0-0.8 - - - - - - - 0-0.8 - - 
≥1:3200 
n 2 1 - - - - - - - - - - - 
% 0.5 0.3 - - - - - - - - - - - 
CI 0-1.3 0-0.8 - - - - - - - - - - - 
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Table 4. Number of individuals, relative prevalence and 95% CI per Leptospira serovar for unvaccinated dogs (n=84). Tested 
serovars: Australis (AUS), Autumnalis (AUT), Ballum (BAL), Bratislava (BRA), Canicola (CAN), Copenhageni (COP), Grippotyphosa 
(GRI), Hardjo (HAR), Icterohaemorrhagie (ICT), Pomona (POM), Pyrogenes (PYR) and Tarassovi (TAR). 
 
MAT 
Titer 
 All 
Serovars AUS BRA COP CAN GRI ICT POM PYR TAR AUT BAL HAR 
≥1:20 
n 55 43 13 19 22 6 6 10 5 4 14 10 1 
% 65.5 51.2 15.5 22.6 26.2 7.1 7.1 11.9 6 4.8 16.7 11.9 1.2 
CI 54.8-75 40.5-61.9 8.3-23.8 14.3-31 16.7-35.7 2.4-13.1 2.4-13.1 6-19 1.2-11.9 1.2-9.5 9.5-25 6-19 0-3.6 
≥1:40 
n 37 17 11 9 11 5 3 4 - 1 7 1 1 
% 44 20.2 13.1 10.7 13.1 6 3.6 4.8 - 1.2 8.3 1.2 1.2 
CI 33.3-53.6 11.9-28.6 6-20.2 4.8-17.9 6-20.2 1.2-11.9 0-8.3 1.2-9.5 - 0-3.6 3.6-14.3 0-3.6 0-3.6 
≥1:100 
n 15 8 7 3 3 3 - 2 - - 2 - - 
% 17.9 9.5 8.3 3.6 3.6 3.6 - 2.4 - - 2.4 - - 
CI 10.7-26.2 3.6-16.6 2.4-14.3 0-8.3 0-8.3 0-8.3 - 0-6 - - 0-6 - - 
≥1:200 
n 10 4 5 2 1 3 - 1 - - 2 - - 
% 11.9 4.8 6 2.4 1.2 3.6 - 1.2 - - 2.4 - - 
CI 6-19 1.2-9.5 1.2-10.7 0-6 0-3.6 0-8.3 - 0-3.6 - - 0-6 - - 
≥1:400 
n 4 - 2 - - - - 1 - - 1 - - 
% 4.8 - 2.4 - - - - 1.2 - - 1.2 - - 
CI 1.2-9.5 - 0-6 - - - - 0-3.6 - - 0-3.6 - - 
≥1:800 
n 1 - 1 - - - - - - - 1 - - 
% 1.2 - 1.2 - - - - - - - 1.2 - - 
CI 0-3.6 - 0-3.6 - - - - - - - 0-3.6 - - 
≥1:1600 
n 1 - - - - - - - - - 1 - - 
% 1.2 - - - - - - - - - 1.2 - - 
CI 0-3.6 - - - - - - - - - 0-3.6 - - 
≥1:3200 
n 2  - - - - - - - - - - - 
% 0.7  - - - - - - - - - - - 
CI 0-1.7  - - - - - - - - - - - 
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Table 5. Number of individuals positive against one, two or more serogroups at a MAT 
Titre of ≥1:40 and MAT ≥1:100. 
 
N° of positive 
Serogroups 
MAT ≥1:40 
n (%) 
MAT ≥1:100 
n (%) 
1 21 (23.1) 58 (62.4) 
2 30 (33.0) 19 (20.4) 
3 25 (27.5)  8 (8.6) 
4 7 (7.7) 6 (6.5) 
5 7 (7.7) 1 (6.5) 
6 1 (1.1) 1 (1.1) 
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Table 6. Risk factors associated with a MAT positivity.  
 
Variable ALL40 ALL100 AUS100 BRA100 GRI100 CAN100 COP100 
Swimming *       
Castrated  * **     
Lives with other animals *   **  * * 
Hunting     **   
Outside >50% of time       * 
Bioregion ** *      
Surroundings *       
Forest *       
Season *       
Age ** **      
Days since last vaccination ** ** ** *   * 
 
* Univariate analysis (p ≤ 0.2) 
** Multivariate analysis (p < 0.05) 
Outcomes: Seropositivity in dogs against any of the tested serovars at MAT cut-offs 
≥1:40 (ALL40) and ≥1:100 (ALL100), seropositivity in dogs at the MAT cut-off ≥1:100 
for serovars Australis (AUS100), Bratislava (BRA100), Grippotyphosa (GRI100), 
Canicola (CAN100) and Copenhageni (COP100). 
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Table 7. Statistically significant risk factors for seropositivity against any serovar at a 
MAT cut-off ≥ 1:40 tested in a multivariable logistic regression model. 
 Covariate Levels Odds ratio 95%CI p-value 
Bioregion 6# Ref.   
 1 11.17 1.69-226.72 0.034* 
 2 12.43 2.04-244.12 0.023* 
 3 14.51 2.23-292.71 0.018* 
 4 5.53 0.63-125.11 0.17 
 5 53.05 3.39-2378.75 0.012* 
Age (years)  1.29 1.13-1.47 0.0001* 
Days since vaccination  1.0008 0.9988-1.0028 0.42 
Days since vaccination*Age  0.9995 0.9992-0.9998 0.0034* 
 
* Statistically significant at p < 0.05, AIC full model = 408.25 & n=301, AIC final model 
= 458.49 & n=347. 
# The numbers correspond with the bioregions (1) Jura, (2) Central Plateau, (3) 
Northern Alps, (4) Central Western Alps, (5) Central Eastern Alps and (6) Southern 
Alps. 
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Table 8. Statistically significant risk factors for seropositivity against any serovar and 
against serovars Australis, Bratislava and Grippotyphosa at a MAT cut-off ≥ 1:100 
tested in multivariable logistic regression models. Associations were considered 
significant if p<0.05. The Akaike information criterion (AIC) is used to indicate the 
relative quality of the used model. 
 Covariate Levels Odds ratio 95%CI p-value 
Risk factors for seropositivity against any serovar at MAT cut-off ≥ 1:100& 
Days since vaccination  1.0011 0.9986-1.0034 0.39 
Age (years)  1.25 1.09-1.43 0.0012* 
Days since vaccination*Age  0.9995 0.9991-0.9999 0.0077* 
Risk factors for seropositivity against serovar Australis at a MAT cut off ≥ 1:100Δ 
Castrated No Ref   
 Yes 1.98 1.08-3.74 0.030* 
Days since vaccination  0.9969 0.995- 0.998 0.0004* 
Risk factors for seropositivity against serovar Bratislava at a MAT cut-off ≥ 1:100♥ 
Dog 1.40 0.49-4.32 0.53 
Cat 2.27 0.72-7.37 0.16 
Dog and Cat 2.40 0.58-9.02 0.20 
Livestock +/-Dog/cat  4.21 0.20-34.77 0.23 
Horses +/- Dog/cat 4.68 1.23-17.19 0.019* 
Risk factors for seropositivity against serovar Grippotyphosa at a MAT cut-off ≥ 1:100# 
Hunting  8.03 1.64-30.82 0.004* 
 
& AIC full model = 361.64 & n=319, AIC final model = 382.36 & n=347. 
Δ AIC full & final model = 296.83 & n=367 
♥AIC full model = 218.26 & n=342, AIC final model = 217.87, n=342 
#AIC full & final model = 126.74 & n=337. 
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